99 related articles for article (PubMed ID: 11783408)
1. [The role of tumor infiltrating lymphocytes in the immunopathology of gliomas].
Geppert A; Patt S
Neurol Neurochir Pol; 2001; 35(4):661-6. PubMed ID: 11783408
[TBL] [Abstract][Full Text] [Related]
2. [Antitumor immune response: what are the roles for gliomas?].
Dietrich PY
Rev Neurol (Paris); 2001 Nov; 157(11 Pt 1):1339-48. PubMed ID: 11924003
[TBL] [Abstract][Full Text] [Related]
3. Phenotype and functional activity of tumor-infiltrating lymphocytes isolated from immunogenic and nonimmunogenic rat brain tumors.
Tzeng JJ; Barth RF; Orosz CG; James SM
Cancer Res; 1991 May; 51(9):2373-8. PubMed ID: 2015600
[TBL] [Abstract][Full Text] [Related]
4. Characterization of PD-1 upregulation on tumor-infiltrating lymphocytes in human and murine gliomas and preclinical therapeutic blockade.
Dejaegher J; Verschuere T; Vercalsteren E; Boon L; Cremer J; Sciot R; Van Gool SW; De Vleeschouwer S
Int J Cancer; 2017 Nov; 141(9):1891-1900. PubMed ID: 28681455
[TBL] [Abstract][Full Text] [Related]
5. Large-scale analysis reveals the specific clinical and immune features of CD155 in glioma.
Liu F; Huang J; Xiong Y; Li S; Liu Z
Aging (Albany NY); 2019 Aug; 11(15):5463-5482. PubMed ID: 31377744
[TBL] [Abstract][Full Text] [Related]
6. Mathematical modeling of PDGF-driven glioma reveals the dynamics of immune cells infiltrating into tumors.
Niu B; Zeng X; Phan TA; Szulzewsky F; Holte S; Holland EC; Tian JP
Neoplasia; 2020 Sep; 22(9):323-332. PubMed ID: 32585427
[TBL] [Abstract][Full Text] [Related]
7. Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas.
Heimberger AB; Abou-Ghazal M; Reina-Ortiz C; Yang DS; Sun W; Qiao W; Hiraoka N; Fuller GN
Clin Cancer Res; 2008 Aug; 14(16):5166-72. PubMed ID: 18698034
[TBL] [Abstract][Full Text] [Related]
8. A critical role for regulatory T cells in driving cytokine profiles of Th17 cells and their modulation of glioma microenvironment.
Cantini G; Pisati F; Mastropietro A; Frattini V; Iwakura Y; Finocchiaro G; Pellegatta S
Cancer Immunol Immunother; 2011 Dec; 60(12):1739-50. PubMed ID: 21779877
[TBL] [Abstract][Full Text] [Related]
9. Irradiated tumor cell vaccine for treatment of an established glioma. I. Successful treatment with combined radiotherapy and cellular vaccination.
Graf MR; Prins RM; Hawkins WT; Merchant RE
Cancer Immunol Immunother; 2002 Jun; 51(4):179-89. PubMed ID: 12012105
[TBL] [Abstract][Full Text] [Related]
10. [Lymphocytic infiltration in cerebral gliomas].
Bucciero A; Cerillo A; Quaglietta P; Villano M; Carraturo S; Vizioli L
Minerva Med; 1992; 83(1-2):25-8. PubMed ID: 1312232
[TBL] [Abstract][Full Text] [Related]
11. Tumor infiltrating immune cells in gliomas and meningiomas.
Domingues P; González-Tablas M; Otero Á; Pascual D; Miranda D; Ruiz L; Sousa P; Ciudad J; Gonçalves JM; Lopes MC; Orfao A; Tabernero MD
Brain Behav Immun; 2016 Mar; 53():1-15. PubMed ID: 26216710
[TBL] [Abstract][Full Text] [Related]
12. Some remarks on adherence reactivity of autologous PHA--transformed lymphocytes on human glial tumor cells in vitro.
Kałuza J; Krzyszkowski T
Folia Neuropathol; 1994; 32(1):21-30. PubMed ID: 7922099
[TBL] [Abstract][Full Text] [Related]
13. Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response.
Sielska M; Przanowski P; Wylot B; Gabrusiewicz K; Maleszewska M; Kijewska M; Zawadzka M; Kucharska J; Vinnakota K; Kettenmann H; Kotulska K; Grajkowska W; Kaminska B
J Pathol; 2013 Jul; 230(3):310-21. PubMed ID: 23520016
[TBL] [Abstract][Full Text] [Related]
14. Progression from low- to high-grade in a glioblastoma model reveals the pivotal role of immunoediting.
Appolloni I; Alessandrini F; Ceresa D; Marubbi D; Gambini E; Reverberi D; Loiacono F; Malatesta P
Cancer Lett; 2019 Feb; 442():213-221. PubMed ID: 30312732
[TBL] [Abstract][Full Text] [Related]
15. Tumor-infiltrating, myeloid-derived suppressor cells inhibit T cell activity by nitric oxide production in an intracranial rat glioma + vaccination model.
Jia W; Jackson-Cook C; Graf MR
J Neuroimmunol; 2010 Jun; 223(1-2):20-30. PubMed ID: 20452681
[TBL] [Abstract][Full Text] [Related]
16. A dendritic cell vaccine induces protective immunity to intracranial growth of glioma.
Insug O; Ku G; Ertl HC; Blaszczyk-Thurin M
Anticancer Res; 2002; 22(2A):613-21. PubMed ID: 12014629
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory Effects of Tryptophan Metabolism in the Glioma Tumor Microenvironment.
Xu Y; Zhang H; Sun Q; Geng R; Yuan F; Liu B; Chen Q
Front Immunol; 2021; 12():730289. PubMed ID: 34659216
[TBL] [Abstract][Full Text] [Related]
18. Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics.
Umemura N; Saio M; Suwa T; Kitoh Y; Bai J; Nonaka K; Ouyang GF; Okada M; Balazs M; Adany R; Shibata T; Takami T
J Leukoc Biol; 2008 May; 83(5):1136-44. PubMed ID: 18285406
[TBL] [Abstract][Full Text] [Related]
19. [Subset analysis of tumor infiltrating lymphocytes and peripheral blood lymphocytes in malignant glioma patients].
Matsuhisa T
No To Shinkei; 1995 May; 47(5):466-73. PubMed ID: 7786623
[TBL] [Abstract][Full Text] [Related]
20. Generation and immunologic functions of Th17 cells in malignant gliomas.
Paladugu M; Thakur A; Lum LG; Mittal S; Parajuli P
Cancer Immunol Immunother; 2013 Jan; 62(1):75-86. PubMed ID: 22752645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
